Based on these findings, it can be speculated on one hand that PDGF-B is a direct lymphangiogenic factor, and on the other, that blockage of PDGFR activation inhibits PDGF-B-induced lymphangiogenesis and limits tumor growth and lymph node metastasis. The gene discussed is PDGFRB; the disease is neoplasm.